HCPCS Level II code S9055 denotes provision of ProcureN or other growth factor preparations used to promote wound healing. These biologic topical agents are increasingly relevant in managing non-healing acute and chronic wounds, pressure injuries, and surgical wound complications. As advanced wound therapies expand, clarity on coding for growth factor preparations matters for clinical documentation, billing consistency, and payer coverage determinations nationally.

Key payers evaluated include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for S9055, how the code is typically used in outpatient wound care and skilled nursing settings, and the common billing considerations tied to application of growth factor products. The publication presents national benchmarks, coding guidance, and policy updates affecting coverage and reimbursement for biologic wound therapies. It also summarizes common modifiers appearing with this service line and highlights documentation elements that tend to influence payer decisions.

This summary is written for clinicians, billing professionals, and policy analysts seeking concise national-level information about coding and policy trends for growth factor wound healing preparations.